{"id":4528,"date":"2024-09-12T11:41:25","date_gmt":"2024-09-12T15:41:25","guid":{"rendered":"https:\/\/herpescureadvocacy.com\/?p=4528"},"modified":"2026-03-24T22:41:29","modified_gmt":"2026-03-25T02:41:29","slug":"board-of-directors-statement-on-gsk-clinical-trial-news","status":"publish","type":"post","link":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/","title":{"rendered":"Board of Directors Statement on GSK Clinical Trial News"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>For Immediate Release<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Media Contact:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Email: info@herpescureadvocacy.com<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u202aP: 267-797-7139\u202c<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Philadelphia, PA<\/strong> &#8211; Herpes Cure Advocacy has learned about the outcome of GSK\u2019s trial of GSK3943104\u00a0which has failed to meet the study\u2019s primary efficacy objective.\u00a0 As a result, this trial will not progress to Phase III studies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While we are disappointed at this news, one thing is clear; there is an urgent and unmet need for better therapeutics for herpes simplex virus types 1 and 2 infections. It is important to note that most clinical trials fail despite very good science or our staunch optimism.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We agree with the GSK statement that \u201c<em>given the unmet medical need and burden associated with genital herpes, innovation in this area is still needed<\/em>\u201d and encourage GSK investors and leadership to stay the course with their dedication to and expertise in herpesviruses. We also encourage private industry leaders to follow the leadership of GSK, Moderna, BioNtech, Assembly Biosciences (Gilead) and others to invest in this therapeutic area. The pipeline is very limited and the need is great.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This news demonstrates the need for more research to benefit the majority of the world\u2019s population who are living with herpes. We need more effective therapies for HSV, and it is our hope that with more dedicated funding we may, finally, improve upon the standard of care. We also need a vaccine to prevent new infections, but very few candidates exist.&nbsp; The challenge is formidable; the efforts must match it.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Herpes Cure Advocacy is grateful to the GSK team and dedicated scientists for doing the hard work of developing a new therapeutic vaccine and leading a global clinical trial. We need and appreciate public health heroes like them who inspire us to lead the charge. We remain cautiously optimistic that the clinical trial results will still produce valuable scientific learnings and that we may see further efforts from GSK to develop another vaccine targeting HSV in the future.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Please join us in charting the course towards a cure. And please donate to<strong> <\/strong><a href=\"https:\/\/herpescureadvocacy.com\/donate-to-support-herpes-cure-advocacy\/\"><strong>Herpes Cure Advocacy<\/strong><\/a> today as we multiply our efforts to promote more scientific advancement in this field of research. We are the only patient advocacy organization globally working to advance the field towards a cure and better therapies for HSV. And we need leadership, partners and resources to continue to move forward.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Onward,&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Herpes Cure Advocacy Board of Directors<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Jeffrey Klausner Board President<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Gary Richwald Board Vice President<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ms. Nicole Hanley Board Treasurer<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Simon Delagrave<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Che Harris<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ms. Karly Kern<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Luis Schang<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Disclosure: Herpes Cure Advocacy is partially funded by GSK.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For Immediate Release Media Contact: Email: info@herpescureadvocacy.com \u202aP: 267-797-7139\u202c Philadelphia, PA &#8211; Herpes Cure Advocacy has learned about the outcome of GSK\u2019s trial of GSK3943104\u00a0which has failed to meet the<a class=\"more-link\" href=\"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/\">Continue reading <span class=\"screen-reader-text\">&#8220;Board of Directors Statement on GSK Clinical Trial News&#8221;<\/span><\/a><\/p>\n","protected":false},"author":205069572,"featured_media":4531,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\n{url}","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":false},"categories":[5967],"tags":[],"class_list":["post-4528","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Board of Directors Statement on GSK Clinical Trial News - Herpes Cure Advocacy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Board of Directors Statement on GSK Clinical Trial News - Herpes Cure Advocacy\" \/>\n<meta property=\"og:description\" content=\"For Immediate Release Media Contact: Email: info@herpescureadvocacy.com \u202aP: 267-797-7139\u202c Philadelphia, PA &#8211; Herpes Cure Advocacy has learned about the outcome of GSK\u2019s trial of GSK3943104\u00a0which has failed to meet theContinue reading &quot;Board of Directors Statement on GSK Clinical Trial News&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/\" \/>\n<meta property=\"og:site_name\" content=\"Herpes Cure Advocacy\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100087212780212\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-12T15:41:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-25T02:41:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Patient Advocate\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@herpesadvocate\" \/>\n<meta name=\"twitter:site\" content=\"@herpesadvocate\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patient Advocate\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/\"},\"author\":{\"name\":\"Patient Advocate\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/person\\\/5a8a408f85fcdaa526d3173c93216d14\"},\"headline\":\"Board of Directors Statement on GSK Clinical Trial News\",\"datePublished\":\"2024-09-12T15:41:25+00:00\",\"dateModified\":\"2026-03-25T02:41:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/\"},\"wordCount\":450,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1\",\"articleSection\":[\"Advocacy\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/\",\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/\",\"name\":\"Board of Directors Statement on GSK Clinical Trial News - Herpes Cure Advocacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1\",\"datePublished\":\"2024-09-12T15:41:25+00:00\",\"dateModified\":\"2026-03-25T02:41:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1\",\"width\":500,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2024\\\/09\\\/12\\\/board-of-directors-statement-on-gsk-clinical-trial-news\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/herpescureadvocacy.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Board of Directors Statement on GSK Clinical Trial News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#website\",\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/\",\"name\":\"Herpes Cure Advocacy\",\"description\":\"Advocating for a cure for Herpes Simplex Virus.\",\"publisher\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/herpescureadvocacy.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#organization\",\"name\":\"Herpes Cure Advocacy\",\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/HCA-main-logo.png?fit=450%2C110&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/HCA-main-logo.png?fit=450%2C110&ssl=1\",\"width\":450,\"height\":110,\"caption\":\"Herpes Cure Advocacy\"},\"image\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=100087212780212\",\"https:\\\/\\\/x.com\\\/herpesadvocate\",\"https:\\\/\\\/www.instagram.com\\\/herpesadvocate\",\"https:\\\/\\\/www.reddit.com\\\/r\\\/HerpesCureAdvocates\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/herpes-cure-advocacy\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@herpes.advocate?lang=en\",\"https:\\\/\\\/themighty.com\\\/groups\\\/herpescureadvocacy\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/person\\\/5a8a408f85fcdaa526d3173c93216d14\",\"name\":\"Patient Advocate\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g\",\"caption\":\"Patient Advocate\"},\"sameAs\":[\"http:\\\/\\\/herpescureadvocacy.com\"],\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/author\\\/herpescureadvocacy\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Board of Directors Statement on GSK Clinical Trial News - Herpes Cure Advocacy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/","og_locale":"en_US","og_type":"article","og_title":"Board of Directors Statement on GSK Clinical Trial News - Herpes Cure Advocacy","og_description":"For Immediate Release Media Contact: Email: info@herpescureadvocacy.com \u202aP: 267-797-7139\u202c Philadelphia, PA &#8211; Herpes Cure Advocacy has learned about the outcome of GSK\u2019s trial of GSK3943104\u00a0which has failed to meet theContinue reading \"Board of Directors Statement on GSK Clinical Trial News\"","og_url":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/","og_site_name":"Herpes Cure Advocacy","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100087212780212","article_published_time":"2024-09-12T15:41:25+00:00","article_modified_time":"2026-03-25T02:41:29+00:00","og_image":[{"width":500,"height":500,"url":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1","type":"image\/jpeg"}],"author":"Patient Advocate","twitter_card":"summary_large_image","twitter_creator":"@herpesadvocate","twitter_site":"@herpesadvocate","twitter_misc":{"Written by":"Patient Advocate","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#article","isPartOf":{"@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/"},"author":{"name":"Patient Advocate","@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/person\/5a8a408f85fcdaa526d3173c93216d14"},"headline":"Board of Directors Statement on GSK Clinical Trial News","datePublished":"2024-09-12T15:41:25+00:00","dateModified":"2026-03-25T02:41:29+00:00","mainEntityOfPage":{"@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/"},"wordCount":450,"commentCount":0,"publisher":{"@id":"https:\/\/herpescureadvocacy.com\/#organization"},"image":{"@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1","articleSection":["Advocacy"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/","url":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/","name":"Board of Directors Statement on GSK Clinical Trial News - Herpes Cure Advocacy","isPartOf":{"@id":"https:\/\/herpescureadvocacy.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#primaryimage"},"image":{"@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1","datePublished":"2024-09-12T15:41:25+00:00","dateModified":"2026-03-25T02:41:29+00:00","breadcrumb":{"@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#primaryimage","url":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1","contentUrl":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1","width":500,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/herpescureadvocacy.com\/"},{"@type":"ListItem","position":2,"name":"Board of Directors Statement on GSK Clinical Trial News"}]},{"@type":"WebSite","@id":"https:\/\/herpescureadvocacy.com\/#website","url":"https:\/\/herpescureadvocacy.com\/","name":"Herpes Cure Advocacy","description":"Advocating for a cure for Herpes Simplex Virus.","publisher":{"@id":"https:\/\/herpescureadvocacy.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/herpescureadvocacy.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/herpescureadvocacy.com\/#organization","name":"Herpes Cure Advocacy","url":"https:\/\/herpescureadvocacy.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2026\/03\/HCA-main-logo.png?fit=450%2C110&ssl=1","contentUrl":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2026\/03\/HCA-main-logo.png?fit=450%2C110&ssl=1","width":450,"height":110,"caption":"Herpes Cure Advocacy"},"image":{"@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100087212780212","https:\/\/x.com\/herpesadvocate","https:\/\/www.instagram.com\/herpesadvocate","https:\/\/www.reddit.com\/r\/HerpesCureAdvocates\/","https:\/\/www.linkedin.com\/company\/herpes-cure-advocacy\/","https:\/\/www.tiktok.com\/@herpes.advocate?lang=en","https:\/\/themighty.com\/groups\/herpescureadvocacy\/"]},{"@type":"Person","@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/person\/5a8a408f85fcdaa526d3173c93216d14","name":"Patient Advocate","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g","caption":"Patient Advocate"},"sameAs":["http:\/\/herpescureadvocacy.com"],"url":"https:\/\/herpescureadvocacy.com\/author\/herpescureadvocacy\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pcZX4e-1b2","jetpack-related-posts":[{"id":1239,"url":"https:\/\/herpescureadvocacy.com\/2022\/05\/19\/new-clinical-trial-for-herpes-simplex-virus\/","url_meta":{"origin":4528,"position":0},"title":"New Clinical Trial for Herpes Simplex Virus","author":"Patient Advocate","date":"May 19, 2022","format":false,"excerpt":"GlaxoSmithKline Pipeline UpdateGSK has officially updated its clinical research pipeline to include a vaccine for HSV-2! Their therapeutic vaccine for HSV-2 isn't mRNA (or what they called SAM technology) but an adjuvanted therapeutic vaccine. The trial (currently recruiting) is a Phase 1\/2 combined trial that ends in 2024. GSK will\u2026","rel":"","context":"With 2 comments","block_context":{"text":"With 2 comments","link":"https:\/\/herpescureadvocacy.com\/2022\/05\/19\/new-clinical-trial-for-herpes-simplex-virus\/#comments"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/05\/download.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":3562,"url":"https:\/\/herpescureadvocacy.com\/2024\/05\/15\/herpes-cure-advocacy-receives-gsk-grant-funding\/","url_meta":{"origin":4528,"position":1},"title":"Herpes Cure Advocacy Receives GSK Grant Funding","author":"Patient Advocate","date":"May 15, 2024","format":false,"excerpt":"Herpes Cure Advocacy is very pleased to announce that the organization has been awarded grant funding from GSK to support it's organizational capacity. Additional partners for supporting organizational capacity are being sought. Supporting organizational capacity allows HCA to continue to advance it's mission of eradicating the world of herpes simplex\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/07\/The_Signal-1-e1731954951554.png?fit=500%2C500&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":2155,"url":"https:\/\/herpescureadvocacy.com\/2023\/04\/08\/latest-updates-on-herpes-cure-treatment-and-prevention\/","url_meta":{"origin":4528,"position":2},"title":"Latest Updates on Herpes Cure Treatment and Prevention","author":"Patient Advocate","date":"April 8, 2023","format":false,"excerpt":"Herpes Cure Advocacy News HHS Listening Sessions: Two listening sessions were held this past week in an effort to gather insights for an addendum to the HHS 2020 STI Strategic Plan. Both patients and providers spoke with OIDP, NIH, and CDC stakeholders about their experiences and ideas for how to\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Website-Headers.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Website-Headers.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Website-Headers.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Website-Headers.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Website-Headers.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/04\/Website-Headers.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2653,"url":"https:\/\/herpescureadvocacy.com\/2023\/07\/16\/new-clinical-trial-registry-ihw-2023-and-more-news\/","url_meta":{"origin":4528,"position":3},"title":"Updates from the Pipeline, IHW 2023 and more news!","author":"Patient Advocate","date":"July 16, 2023","format":false,"excerpt":"Hello, The Latest News in Herpes Advocacy is here. Enjoy reading the latest news? Want to see progress faster? Support our work today. Healthy Volunteers Needed for BNT163-01 Clinical Trial Healthy volunteers sought for clinical trial for herpes vaccine candidate from BioNtech BNT-163-01. Volunteers needed near\u00a0The University of Pennsylvania Hospital\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/07\/pngtree-twitter-social-media-round-icon-png-image_6315985.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1861,"url":"https:\/\/herpescureadvocacy.com\/2022\/12\/30\/biontech-new-clinical-trial-for-herpes-vaccine-begins\/","url_meta":{"origin":4528,"position":4},"title":"BioNTech New Clinical Trial for Herpes Vaccine begins","author":"Patient Advocate","date":"December 30, 2022","format":false,"excerpt":"December 21 2022, BioNTech announced they had dosed the first clinical trial participant. This is the first-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate BNT163. Company statement; \u201cWe aim to help address diseases with a high unmet medical need and of global health\u2026","rel":"","context":"With 1 comment","block_context":{"text":"With 1 comment","link":"https:\/\/herpescureadvocacy.com\/2022\/12\/30\/biontech-new-clinical-trial-for-herpes-vaccine-begins\/#comments"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":4231,"url":"https:\/\/herpescureadvocacy.com\/2024\/08\/03\/herpes-impact-on-brain-health-new-study-indicates-shringix-vaccine-prevents-dementia\/","url_meta":{"origin":4528,"position":5},"title":"Herpes Impact on Brain Health: New study indicates Shringix Vaccine prevents dementia","author":"Patient Advocate","date":"August 3, 2024","format":false,"excerpt":"Experts insist we are at a tipping point in scientific research relating to herpesviruses impact on dementia and Alzheimer's Disease. Last month a new study from a team in Australia indicated that vaccination against Varicella Zoster (VZV) with the Shingles vaccine was found to be preventative against dementia. Read this\u2026","rel":"","context":"In &quot;Herpes Cure Research&quot;","block_context":{"text":"Herpes Cure Research","link":"https:\/\/herpescureadvocacy.com\/category\/herpes-cure\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts\/4528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/users\/205069572"}],"replies":[{"embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/comments?post=4528"}],"version-history":[{"count":4,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts\/4528\/revisions"}],"predecessor-version":[{"id":4535,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts\/4528\/revisions\/4535"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/media\/4531"}],"wp:attachment":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/media?parent=4528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/categories?post=4528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/tags?post=4528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}